EUVIMEDEUVIMED entdecken
Crossref

Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs

Akiko TANAKA

Hosokawa Powder Technology Foundation ANNUAL REPORT · 26.05.2026 · 33 · 66-69

DOI: 10.14356/hptf.23109 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hosokawa Powder Technology Foundation ANNUAL REPORT, erschienen am 26.05.2026. Verfasst von Akiko TANAKA. Die Arbeit nennt 5 Literaturangaben. Gefördert von: Hosokawa Powder Technology Foundation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • Hosokawa Powder Technology Foundation

Zitieren

APA

TANAKA, A. (2026). Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs. Hosokawa Powder Technology Foundation ANNUAL REPORT, 33(0), 66-69. https://doi.org/10.14356/hptf.23109

Vancouver

TANAKA A. Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs. Hosokawa Powder Technology Foundation ANNUAL REPORT. 2026;33(0):66-69. doi:10.14356/hptf.23109

BibTeX
@article{TANAKA2026,
  author = {TANAKA, Akiko},
  title = {Development of Intranasal Powder Formulations for Brain-Targeted Delivery of Peptide Drugs},
  journal = {Hosokawa Powder Technology Foundation ANNUAL REPORT},
  year = {2026},
  volume = {33},
  number = {0},
  pages = {66--69},
  doi = {10.14356/hptf.23109}
}
Kostenlos starten →